One-carbon Therapeutics AB announces the addition of multiple international experts to its Scientific Advisory Board

Professor Johann de Bono, Head of the Division of Clinical Studies and Drug Development Unit and Experimental Cancer Medicine at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, UK. 

Professor Timothy Yap, Vice President and Head of Clinical Development in the Therapeutics Discovery Division, The Institute for Applied Cancer Science MD Anderson Cancer Center, Houston, US

Professor Ruth Plummer, Experimental Cancer Medicine, Newcastle University. Director of the Sir Bobby Robson Cancer Trials Research Centre and, Newcastle Experimental Cancer Medicine Centre and CRUK Newcastle Cancer Centre, UK

We are very pleased to bring together world leaders in clinical drug development that are excited about our mission of bringing better new drugs to cancer patients. Our SAB will actively shape the company’s clinical strategy guided by a strong scientific rationale. 

Rekommenderade artiklar